Characterization of MID-NET<sup>®</sup> Data for Appropriate Drug Safety Assessment： Lessons Learned from Studies Investigating Incidence of Decreased Liver Function in Patients Prescribed Drugs for Pulmonary Arterial Hypertension and Examining Real World Utilization of Biosimilars-Reference-Cited by-同舟云学术

Characterization of MID-NET<sup>®</sup> Data for Appropriate Drug Safety Assessment： Lessons Learned from Studies Investigating Incidence of Decreased Liver Function in Patients Prescribed Drugs for Pulmonary Arterial Hypertension and Examining Real World Utilization of Biosimilars

Published:2022 Issue: Volume: Page:
ISSN:1342-0445
Container-title:Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku
language:en
Short-container-title:Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku

Author:

KOMAMINE Maki¹,HASEGAWA Tomoaki¹,ANDO Takashi¹,UYAMA Yoshiaki¹

Affiliation:

1. Pharmaceuticals and Medical Devices Agency, Japan

Publisher

Japanese Society for Pharmacoepidemiology

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jjpe/advpub/0/advpub_28.e1/_pdf

Reference21 articles.

1. 1) Ishiguro C, Takeuchi Y, Uyama Y, Tawaragi T. The MIHARI project： establishing a new framework for pharmacoepidemiological drug safety assessments by the Pharmaceuticals and Medical Devices Agency of Japan. Pharmacoepidemiol Drug Saf 2016；25（7）： 854-9.

2. 2) 独立行政法人医薬品医療機器総合機構．MID-NET （Medical Information Database Network）．［https://www.pmda.go.jp/safety/mid-net/0001.html (accessed 2022-4-9）］

3. 3) Yamaguchi M, Inomata S, Harada S, et al. Establishment of the MID-NET^® medical information database network as a reliable and valuable database for drug safety assessments in Japan. Pharmacoepidemiol Drug Saf 2019； 28（10）：1395-404.

4. 4) 独立行政法人医薬品医療機器総合機構．わかる！MID-NET^®．［https://www.pmda.go.jp/files/000233711.pdf（accessed 2022-4-9）］

5. 5) Sawada S, Ando T, Hirano M, et al. Effect of hepatitis C drugs on blood coagulability in patients on warfarin using the Medical Information Database Network （MID-NET^®） in Japan. Ther Innov Regul Sci 2021；55（3）：539-44.